.jpg?width=2560&height=1440&name=2003-009%20(2).jpg)
Featured Post
Red Dot: Best of the Best — The PharmaPrinter Aurum Takes Design's Highest Honor
Red Dot: Best of the Best — The PharmaPrinter Aurum Takes Design's Highest Honor
Some weeks you remember forever. Days after signing our $14M Series A, our team walked onto the Red Dot stage in Essen, Germany, to accept the Best of the Best award for the PharmaPrinter Aurum — the jury's highest distinction, reserved for the most groundbreaking product designs of the year.
Let's be honest about what that stage looks like. The Red Dot Award: Product Design is where the giants of industrial design collect their trophies — global consumer electronics brands, automotive icons, design houses with decades of heritage. And there we were, a Finnish health technology company that makes pharmaceutical compounding equipment, standing with the big boys on stage. We belonged there, and the trophy agrees.
CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine
CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine
NEWS FROM SWEDEN: First delivery of extemporaneous medicinal products manufactured using 3D technology
https://press.apl.se/posts/pressreleases/forsta-leveransen-av-extemporelakemedel-tillv
CurifyLabs Unveils Next Gen 3D Printer for Scalable Plug-and-Play Pharmaceutical Compounding
CurifyLabs PharmaPrinter Aurum
Press Release: CurifyLabs Launches CuraBlend®Vet, Bringing Breakthrough 3D-Printed, Personalized Medicines to Pets
CurifyLabs introduces CuraBlend®Vet, a 3D-printed, flavored gel tablet for pets, improving adherence and simplifying medication administration with personalized dosages.
Press Release: New data shows compounded medicines tackle the unmet needs and improve adherence to treatment for pediatric cancers
Press release CurifyLabs New data shows compounded medicines tackle the unmet needs and improve adherence to treatment for pediatric cancers.
CurifyLabs Leads €5.6M EU-Funded RoboPharma Project and raised €6.7M to Modernise Personalised Medicine!
CurifyLabs raises €6.7M and leads a €5.6M EU-funded RoboPharma project to revolutionize the manufacturing of personalized medicine with automation and AI.
APL and CurifyLabs partnership to support critically ill patients with 3D printing medicine technology
CurifyLabs to partner with APL
CurifyLabs’ Technology Validated in European-Wide Study
CurifyLabs peer reviewed article, Delpech Paris, Charite, Helios, Lausanne University Hospital, Mainz University Hospital